Inactive Instrument

News Genzyme Corporation

Equities

US3729171047

End-of-day quote Nasdaq Other stock markets
- ^USD	-

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

GENZYME CORP.GNL : Mipomersen Data Presented at European Atherosclerosis Society Congress	11-06-28	PU
GENZYME CORP.GNL : Genzyme Board Unanimously Recommends that Shareholders Accept sanofi-aventis Revised Offer and Tender Shares	11-03-07	BU
GENZYME CORP.GNL : Genzyme Completes Sale of Pharmaceuticals Business to International Chemical Investors Group	11-03-01	BU
GENZYME CORP.GNL : Genzyme Recognizes International Rare Disease Day by Launching New Patient Advocacy Grant Program	11-02-28	BU
GENZYME CORP.GNL : Three-Year Data from Phase 2 Trial of Genzyme Gaucher Disease Oral Compound Suggest Sustained or Further Improvement Across All Endpoints	11-02-18	BU
GENZYME CORP.GNL : Genzyme Reports Financial Results for Fourth Quarter of 2010 and Full Year	11-02-16	BU
GENZYME CORP.GNL : Genzyme Completes Sale of Diagnostics Business to Sekisui Chemical Co.	11-02-01	BU
GENZYME CORP.GNL : Genzyme Will Allow Sanofi-Aventis to Conduct Due Diligence	11-01-31	BU
GENZYME CORP.GNL : Genzyme to Build Additional Plant to Support Growth of Myozyme® and Lumizyme®	11-01-20	BU
GENZYME CORP.GNL : Genzyme Financial Recovery Continues in Fourth Quarter	11-01-11	BU
GENZYME CORP.GNL : Genzyme Statement on Discussions With Sanofi-Aventis	11-01-10	BU
GENZYME CORP.GNL : Genzyme Details Market Potential of Alemtuzumab for MS	10-12-20	BU
GENZYME CORP.GNL : Genzyme to Hold Investor Event on Alemtuzumab	10-12-13	BU
GENZYME CORP.GNL : Genzyme Reiterates Board's Position on Sanofi-Aventis Tender Offer	10-12-13	BU
GENZYME CORP.GNL : Genzyme Completes Sale of Genetic Testing Business to LabCorp	10-12-01	BU
GENZYME CORP.GNL : Genzyme Successfully Meets First Milestones of FDA Consent Decree	10-11-24	BU
GENZYME CORP.GNL : Genzyme Announces Agreement to Sell Diagnostics Business to Sekisui Chemical Co.	10-11-18	BU
GENZYME CORP.GNL : Genzyme Responds to Sanofi-Aventis Letter	10-11-08	BU
GENZYME CORP.GNL : Genzyme Details Financial Recovery and Other Factors Driving Company's Value	10-10-22	BU
GENZYME CORP.GNL : Genzyme Announces Webcast of Analyst and Investor Event	10-10-21	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Genzyme Corporation

Equities

US3729171047

Summary

Filters